Swaminathan, M. and Ravandi, F. (2023) “Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia?”, Haematologica. Pavia, Italy, 108(10), pp. 2561-2563. doi: 10.3324/haematol.2023.283120.